| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 32.55B | 31.05B | 25.15B | 21.02B | 21.53B | 20.71B |
| Gross Profit | 32.55B | 31.05B | 25.15B | 14.49B | 17.27B | 14.49B |
| EBITDA | 9.64B | 10.14B | 8.88B | 5.90B | -2.92B | -2.75B |
| Net Income | 6.28B | 5.99B | 5.73B | 3.56B | -3.32B | -3.11B |
Balance Sheet | ||||||
| Total Assets | 120.35B | 116.18B | 112.42B | 68.60B | 67.82B | 54.50B |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 17.23B | 24.42B | 5.72B | 3.76B | 2.06B |
| Total Debt | 1.23B | 1.29B | 219.00M | 115.00M | 7.00M | 11.00M |
| Total Liabilities | 25.03B | 24.06B | 21.54B | 53.03B | 45.75B | 38.70B |
| Stockholders Equity | 95.31B | 92.11B | 90.87B | 75.69B | 22.07B | 15.81B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.10B | 5.23B | 2.12B | 2.27B | 2.11B |
| Operating Cash Flow | 0.00 | 7.28B | 6.02B | 2.68B | 2.78B | 2.94B |
| Investing Cash Flow | 0.00 | -14.29B | -3.44B | 763.00M | -7.75B | -10.44B |
| Financing Cash Flow | 0.00 | -164.00M | 9.68B | -109.00M | 9.67B | 8.88B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥1.75T | 17.60 | ― | 2.44% | -21.38% | 58.05% | |
71 Outperform | ¥35.70B | 7.00 | 4.94% | 4.00% | 10.72% | 293.23% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥174.58B | 22.15 | ― | ― | 20.22% | 19.40% | |
67 Neutral | ¥5.34T | 7.36 | 10.61% | 3.26% | -8.02% | 5.21% | |
61 Neutral | ¥1.70T | 10.62 | 7.91% | 2.74% | -1.96% | 10.32% | |
46 Neutral | ¥4.25B | -4.99 | 4.15% | ― | -6.60% | ― |